Compounded sterile products
Product details
- Compounded sterile products
Company announcement
Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of compounded sterile products nationwide.
The recall is due to a potential lack of sterility assurance, following an FDA inspection and internal evaluation.
The affected products were dispensed between August 10, 2026, and September 21, 2026.
No adverse events, injuries, or deaths have been reported to date related to this recall.
Risk:
Use of a drug product intended to be sterile, that is not sterile, could result in serious infections, which may be life threatening. Greenwich Rx has not identified any evidence of contamination in the recalled products; however, Greenwich Rx is initiating this recall as a precautionary measure. To date, Greenwich Rx has not received any reports of adverse events related to this recall.
Impacted states: Nationwide
Contact
For more information, email 888-243-5547.